MeiraGTx Holdings (MGTX)

• Market cap: $613M
• 1 day: -1.68%
• 5 days: -5.23%
• 1 month: -3.3%
• 3 months: -12.83%
• 6 months: -3.55%
• Year to date: -2.56%
• 1 year: 18.35%
• 5 years: -50.65%
• 10 years: -49.27%
• Sector: Healthcare
• Industry: Biotechnology

About: MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Employees: 409